BC
Birchview Capital’s Nektar Therapeutics NKTR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-28,000
| Closed | -$16.7K | – | 59 |
|
2023
Q3 | $16.7K | Hold |
28,000
| – | – | 0.01% | 50 |
|
2023
Q2 | $16.1K | Sell |
28,000
-90,000
| -76% | -$51.8K | 0.01% | 54 |
|
2023
Q1 | $83K | Hold |
118,000
| – | – | 0.07% | 52 |
|
2022
Q4 | $267K | Sell |
118,000
-10,000
| -8% | -$22.6K | 0.19% | 45 |
|
2022
Q3 | $410K | Hold |
128,000
| – | – | 0.29% | 41 |
|
2022
Q2 | $486K | Hold |
128,000
| – | – | 0.35% | 38 |
|
2022
Q1 | $690K | Buy |
128,000
+28,000
| +28% | +$151K | 0.5% | 35 |
|
2021
Q4 | $1.35M | Buy |
100,000
+28,000
| +39% | +$378K | 0.87% | 22 |
|
2021
Q3 | $1.29M | Hold |
72,000
| – | – | 0.88% | 24 |
|
2021
Q2 | $1.24M | Sell |
72,000
-20,000
| -22% | -$343K | 0.74% | 23 |
|
2021
Q1 | $1.84M | Buy |
+92,000
| New | +$1.84M | 1.09% | 16 |
|
2019
Q3 | – | Sell |
-9,500
| Closed | -$338K | – | 54 |
|
2019
Q2 | $338K | Hold |
9,500
| – | – | 0.21% | 38 |
|
2019
Q1 | $319K | Hold |
9,500
| – | – | 0.2% | 41 |
|
2018
Q4 | $312K | Hold |
9,500
| – | – | 0.3% | 35 |
|
2018
Q3 | $579K | Hold |
9,500
| – | – | 0.37% | 29 |
|
2018
Q2 | $464K | Buy |
+9,500
| New | +$464K | 0.32% | 32 |
|